LEADER 01428nam  2200361z- 450 
001 9910694344603321
005 20070810082758.0
035   $a(CKB)5860000000030927
035   $a(BIP)015719170
035   $a(EXLCZ)995860000000030927
100   $a20220406c2007uuuu  -u-         -
101 0 $aeng
200 10$aPharmaceutical supply chain security $ehearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, July 11, 2006
215   $a1 online resource (iii, 131 p.) 
311   $a0-16-079007-7 
517   $aPharmaceutical supply chain security 
606   $aDrugs$xMarketing$xCorrupt practices$zUnited States$xPrevention
606   $aPharmaceutical industry$xSecurity measures$zUnited States
606   $aProduct counterfeiting$zUnited States$xPrevention
610   $aDrugs
610   $aPharmaceutical industry
610   $aProducts liability
610   $aCounterfeits and counterfeiting
610   $aBusiness & economics
610   $aLaw
610   $aSocial science
615  0$aDrugs$xMarketing$xCorrupt practices$xPrevention.
615  0$aPharmaceutical industry$xSecurity measures
615  0$aProduct counterfeiting$xPrevention.
906   $aBOOK
912   $a9910694344603321
996   $aPharmaceutical supply chain security$93133458
997   $aUNINA